CellCentric Ltd.
Highfield Court
Church Lane
Madingley
Cambridge
CB3 8AG
United Kingdom
Tel: 44-0-1954-213498
Fax: 44-0-1954-213495
Website: http://www.cellcentric.co.uk/
12 articles about CellCentric Ltd.
-
CellCentric Ltd. Selects Sygnature Discovery (Formerly known as Sygnature Chemical Services) for Epigenetic Prostate Cancer Program
9/9/2013
-
CellCentric Ltd. and ZoBio Enter into Partnership to Develop Lead Compounds Against Epigenetic Drug Targets
6/20/2012
-
CellCentric Ltd. Licenses Novel Epigenetic Discovery Program to Takeda Pharmaceutical Co. Ltd. (JOBS); Deal Could be Worth Excess of $200 Million
2/23/2010
-
CellCentric Ltd. Secures 25th Epigenetics Academic Agreement
4/21/2009
-
CellCentric Ltd. Expands its Leadership Team
2/4/2009
-
CellCentric Ltd. and Takeda Pharmaceutical Co. Ltd. Collaborate on Epigenetic Programme
1/6/2009
-
Following Success of Pilot, Cenix BioScience GmbH Takes on Second RNAi-Based Target Validation Project for CellCentric Ltd.
7/1/2008
-
Cenix BioScience GmbH and CellCentric Ltd. Second RNAi-Based Target Validation Project
7/1/2008
-
Cenix BioScience GmbH and CellCentric Ltd. Sign Framework Research Agreement for RNAi-Based Target Validation
3/20/2008
-
CellCentric Ltd. and Cancer Research Technology Collaborate on Epigenetic Discoveries
11/14/2007
-
Argenta Discovery Inc. Announces Contract Drug Discovery Collaboration with CellCentric Ltd.
10/3/2007
-
CellCentric Ltd. Receives £1.15M DTI Award
5/4/2006